View in EDS HTML Full Text PDF Full Text

Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.

Saved in:
Bibliographic Details
Title: Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
Authors: Tronieri JS; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, jena.tronieri@pennmedicine.upenn.edu., Fabricatore AN; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Wadden TA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Auerbach P; Novo Nordisk A/S, Søborg, Denmark., Endahl L; Novo Nordisk A/S, Søborg, Denmark., Sugimoto D; Cedar Crosse Research Center, Chicago, Illinois, USA., Rubino D; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
Source: Obesity facts [Obes Facts] 2020; Vol. 13 (6), pp. 572-583. Date of Electronic Publication: 2020 Nov 16.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 101469429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1662-4033 (Electronic) Linking ISSN: 16624025 NLM ISO Abbreviation: Obes Facts Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33197917
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tronieri+JS%22">Tronieri JS</searchLink>; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA, jena.tronieri@pennmedicine.upenn.edu.<br /><searchLink fieldCode="AU" term="%22Fabricatore+AN%22">Fabricatore AN</searchLink>; Novo Nordisk Inc., Plainsboro, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Wadden+TA%22">Wadden TA</searchLink>; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Auerbach+P%22">Auerbach P</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Endahl+L%22">Endahl L</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Sugimoto+D%22">Sugimoto D</searchLink>; Cedar Crosse Research Center, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Rubino+D%22">Rubino D</searchLink>; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101469429%22">Obesity facts</searchLink> [Obes Facts] 2020; Vol. 13 (6), pp. 572-583. <i>Date of Electronic Publication: </i>2020 Nov 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101469429 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1662-4033 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216624025%22">16624025 </searchLink><i>NLM ISO Abbreviation: </i>Obes Facts <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33197917
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000511130
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 572
    Titles:
      – TitleFull: Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tronieri JS
      – PersonEntity:
          Name:
            NameFull: Fabricatore AN
      – PersonEntity:
          Name:
            NameFull: Wadden TA
      – PersonEntity:
          Name:
            NameFull: Auerbach P
      – PersonEntity:
          Name:
            NameFull: Endahl L
      – PersonEntity:
          Name:
            NameFull: Sugimoto D
      – PersonEntity:
          Name:
            NameFull: Rubino D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1662-4033
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Obesity facts
              Type: main
ResultId 1